Spots Global Cancer Trial Database for Retrospective Study on the Incidence and Management of Anemia in Oncology
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Retrospective Study on the Incidence and Management of Anemia in Oncology
Official Title: Retrospective Study on the Incidence and Management of Anemia in Oncology
Study ID: NCT04779840
Interventions
Study Description
Brief Summary: The incidence of anemia ranges from 20 to 75% depending on the type of cancer. It is often present at diagnosis and increases with specific treatments. It has an impact on overall survival and quality of life. Its origins are multiple (pure iron deficiency or functional, malnutrition, dyserythropoiesis, insufficiency renal, hemolysis, chemotherapy, radiotherapy, targeted therapies). Transfusion is the most common treatment offered in the management of anemia. The incidence of anemia and its consequences are often underestimated during cancer management. Recommendations were published in 2012. An inventory of the incidence of anemia before and after the publication of these recommendations are proposed in order to assess their impact on daily practice.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre Jean Bernard - Clinique Victor Hugo, Le Mans, , France
Contact Details
Name: Katell LE DÛ, MD
Affiliation: Centre Jean Bernard/Clinique Victor Hugo - LE MANS
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
